SOHM, Inc., to focus growth on Rx-to-OTC Switches with private label products
SOHM, Inc. to take advantage of the FDA converting more prescription Products to the over-the-counter Markets (OTC) CHINO HILLS, CA / ACCESSWIRE / May 12, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today that they continue to focus on the growth opportunities with the acquisition footprint, and focus major expansion growth in the Rx to OTC products that are coming off of the prescription products list. Mr. Baron Night, President and CEO of SOHM Inc. said, "With over 80% of the American consumers preferring private label products for cost reasons, this becomes a space that SOHM feels it can expand and capitalize on monetarily for the near and distant future. With online retail giants recently launching their own private labels of OTC products, more opportunity for this type of private label manufacturing has made its mark in the US. This can also lead to strategic partnerships with bigger retail outlets as well as other logistical development of new OTC products. Our goal is to make our products available to the world while preserving the integrity of the SOHM brands " US brands in its strategic alliance manufacturing facility at Southern California thus increasing the profitability. If earlier announced proposed acquisition goes through, it is in line with the Company's strategy for its growth and stability and bring synergies between the two companies. The company anticipates announcing its definitive agreement after proper due diligence and procuring confirmed financing methods within 2nd qtr. 2021 or early 3rd qtr. About SOHM, Inc. Safe Harbor Statement: For more information, please contact: SOURCE: Sohm, Inc.
05/12/2021 EQS Newswire / EQS Group AG |
Editor Details
-
Company:
- EQS Newsfeed
- Website: